Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics (Q44537877)

3 December 2017

title

Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics (English)

1 reference

3 December 2017

1 reference

Thomas Mandrup-Poulsen

1 reference

3 December 2017

J Nerup

1 reference

3 December 2017

C R Stiller

1 reference

3 December 2017

B Marner

1 reference

3 December 2017

G Bille

1 reference

3 December 2017

D Heinrichs

1 reference

3 December 2017

R Martell

1 reference

3 December 2017

J Dupre

1 reference

3 December 2017

P A Keown

1 reference

3 December 2017

M R Jenner

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 March 1985

1 reference

3 December 2017

1 reference

3 December 2017

1 reference

3 December 2017

issue

8429

1 reference

3 December 2017

page(s)

599-602

1 reference

HL-A antigens and diabetes mellitus.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Partial preservation of pancreatic beta-cell function in children with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Effect of cyclosporin A (CyA) on the immune response. CyA competitively inhibits the function of monocyte/macrophage-derived T-lymphocyte-activating factor(s)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Cyclosporin prevents diabetes in BB Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Islet-cell antibodies and beta-cell function in insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Residual beta-cell function and islet cell antibodies in diabetic children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Islet Function in Diabetics with Persistent Islet Cell Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Islet-Cell Antibodies and Beta-Cell Function in Monozygotic Triplets and Twins Initially Discordant for Type I Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Analysis of islet cell antibodies on frozen sections of human pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Spontaneous in vitro immunoglobulin secretion at the diagnosis of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Exacerbation of Systemic Lupus Erythematosus after Withdrawal of Azathioprine Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Disappearing anti-islet antibodies?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Islet-cell antibodies are seldom transient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

Immunological and pharmacological monitoring in the clinical use of cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992143-9

7 January 2021

10.1016/S0140-6736(85)92143-9

Identifiers

DOI

1 reference

release_ez3hxnzsv5bz5ekzky7sehpyze

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ez3hxnzsv5bz5ekzky7sehpyze

24 November 2022

mapped directly with Wikidata item

1 reference